HC Wainwright Reiterates Buy Rating for Dyadic International

DYAI Stock  USD 1.71  0.16  8.56%   
Under 67% of Dyadic International's investor base is looking to short. The analysis of the overall investor sentiment regarding Dyadic International suggests that many traders are alarmed. Dyadic International's investing sentiment shows overall attitude of investors towards Dyadic International.
  
Dyadic International s stock had its buy rating reissued by HC Wainwright in a research report issued to clients and investors on Friday, Benzinga reports. They currently have a 6.00 price objective on the biotechnology companys stock. HC Wainwrights price target would suggest a potential upside of 222.58 percent from the companys current

Read at thelincolnianonline.com
news
  

Dyadic International Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Dyadic International can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Dyadic International Fundamental Analysis

We analyze Dyadic International's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dyadic International using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dyadic International based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Number Of Employees

Number Of Employees Comparative Analysis

Dyadic International is currently under evaluation in number of employees category among its peers. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.

Dyadic International Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Dyadic International stock to make a market-neutral strategy. Peer analysis of Dyadic International could also be used in its relative valuation, which is a method of valuing Dyadic International by comparing valuation metrics with similar companies.

Peers

Dyadic International Related Equities

ANTXAN2 Therapeutics   21.90   
0%
100.0%
FBRXForte Biosciences   9.70   
0%
44.0%
DMACDiaMedica Therapeutics   8.64   
0%
39.0%
CCCCC4 Therapeutics   8.59   
0%
39.0%
CSBRChampions Oncology   4.87   
0%
22.0%
MNOVMediciNova   2.99   
0%
13.0%
EWTXEdgewise Therapeutics   2.48   
0%
11.0%
HOWLWerewolf Therapeutics   1.52   
0%
6.0%
PMVPPmv Pharmaceuticals   1.25   
0%
5.0%
ANEBAnebulo Pharmaceuticals   0.70   
0%
3.0%
MOLNMolecular Partners   0.17   
1.0%
0%
CELCCelcuity LLC   0.39   
1.0%
0%
ELYMEliem Therapeutics   5.88   
26.0%
0%
HCWBHCW Biologics   6.00   
27.0%
0%

Complementary Tools for Dyadic Stock analysis

When running Dyadic International's price analysis, check to measure Dyadic International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dyadic International is operating at the current time. Most of Dyadic International's value examination focuses on studying past and present price action to predict the probability of Dyadic International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dyadic International's price. Additionally, you may evaluate how the addition of Dyadic International to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance